Novo Nordisk A/S

$65.15
NVO - NYSE
Dividend yield
Dividend has grown by 15.7% in last three years.
2.42 %
$1.237 anually
P/E ratio
-
Payout ratio
Proportion of net income paid out as dividends to shareholders
-
Yearly
Company profitability (EPS)
-
past 12 months
CASH payout ratio
Novo Nordisk A/S last quarter cash income being paid in the form of dividends.
Last quarter
Become our supporter to unlock all data!
Stock volatility (Beta)
See how volatile NVO stock is compared to other dividend stocks and to its sector
past 12 months
Become our supporter to unlock all data!
Company debt level
How much debt Novo Nordisk A/S have in comparison to other dividend stocks
Become our supporter to unlock all data!
Novo Nordisk A/S description

Novo Nordisk A/S is a healthcare company, which engages in the research, development, manufacture, and marketing of pharmaceutical products. It operates through the following segments: Diabetes & Obesity Care, and Biopharmaceuticals. The Diabetes & Obesity Care segment covers products for insulin; GLP-1 and related delivery systems; oral antidiabetic products; and obesity.

The Biopharmaceuticals segment offers products for haemophilia; growth hormone therapy; and hormone replacement therapy.

Company profile
Market cap
Mega (117.12B)
Company CEO
Lars Fruergaard Jørgensen
Price history Novo Nordisk A/S
Loading price stock history...
NVO dividends payouts
Similar stocks as Novo Nordisk A/S